Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.
Profitability
This table compares Rapid Micro Biosystems and PROCEPT BioRobotics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Rapid Micro Biosystems | -140.30% | -95.40% | -58.85% |
| PROCEPT BioRobotics | -31.02% | -25.13% | -18.63% |
Valuation and Earnings
This table compares Rapid Micro Biosystems and PROCEPT BioRobotics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rapid Micro Biosystems | $33.59 million | 2.94 | -$47.12 million | ($1.07) | -2.03 |
| PROCEPT BioRobotics | $308.05 million | 4.24 | -$95.57 million | ($1.71) | -13.56 |
Rapid Micro Biosystems has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Rapid Micro Biosystems and PROCEPT BioRobotics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rapid Micro Biosystems | 1 | 0 | 1 | 0 | 2.00 |
| PROCEPT BioRobotics | 2 | 4 | 8 | 0 | 2.43 |
Rapid Micro Biosystems presently has a consensus target price of $8.00, indicating a potential upside of 268.66%. PROCEPT BioRobotics has a consensus target price of $40.82, indicating a potential upside of 76.02%. Given Rapid Micro Biosystems’ higher possible upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than PROCEPT BioRobotics.
Insider and Institutional Ownership
52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 30.0% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
Rapid Micro Biosystems has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
Summary
PROCEPT BioRobotics beats Rapid Micro Biosystems on 8 of the 14 factors compared between the two stocks.
About Rapid Micro Biosystems
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
